Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice

Microvascular Research

Volumn 82, Issue 3, 2011, Pages 227-236

  Dong, Li ^a   Kang, Lina ^a   Ding, Liang ^a   Chen, Qin ^a   Bai, Jian ^a   Gu, Rong ^a   Li, Lixin ^b   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENHANCED GREEN FLUORESCENT PROTEIN; GELATINASE B; INSULIN GLARGINE; IRON; NEODYMIUM; PROTEIN KINASE B; RECOMBINANT HUMAN INSULIN; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAPILLARY DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HINDLIMB; LIMB ISCHEMIA; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHEMOKINE CXCL12; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GREEN FLUORESCENT PROTEINS; HINDLIMB; HYPOGLYCEMIC AGENTS; INSULIN; ISCHEMIA; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS;

EID: 81055140207     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.09.006     Document Type: Article

References (35)

1. Ackah E., Yu J., Zoellner S., Iwakiri Y., Skurk C., Shibata R. Akt1/protein kinase B alpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Investig. 2005, 115:2119-2127.
2. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 2003, 9:1370-1376.
3. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
4. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
5. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999, 18:3964-3972.
6. Caballero S., Sengupta N., Afzal A., Chang K.H., Calzi S.L., Dennis L. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007, 56:960-967.
7. Catrina S.B., Okamoto K., Pereira T., Brismar K., Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1a protein stability and function. Diabetes 2004, 53:3226-3232.
8. Ceradini D.J., Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 2005, 15:57-63.
9. Chen Q., Dong L., Wang L., Kang L.N., Xu B. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Biochem. Biophys. Res. Commun. 2009, 381:192-197.
10. Chou E., Suzuma I., Way K.J., Opland D., Clermont A.C., Naruse K., Suzuma K., Bowling N.L., Vlahos C.J., Aiello L.P., King G.L. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic sates: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002, 105:373-379.
11. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am. J. Pathol. 1998, 152:1667-1679.
12. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2005, 45:1449-1457.
13. Foteinos G., Hu Y., Xiao Q.Z., Metzler B., Xu Q.B. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein e-deficient mice. Circulation 2008, 117:1856-1863.
14. Gallagher K.A., Liu G.A., Xiao M., Chen H., Goldstein L.J., Buerk D.G., Nedeau A., Stephen R., Thom S.R., Omaida C., Velazquez O.C. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J. Clin. Invest. 2007, 117:1249-1259.
15. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
16. Hiasa S.K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S. Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway. Circulation 2004, 109:2454-24611.
17. Humpert P.E., Neuwirth R., Battista M.J., Voronko O., Konrade I., Rudofsky G., Wendt T., Hamann A., Morcos M., Nawroth P.P., Bierhaus A. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diab. Care 2005, 28:934-936.
18. Humpert P.M., Djuric Z., Zeuge U., Oikonomou D., Seregin Y., Laine K., Eckstein V., Nawroth P.P., Bierhaus A. Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol. Med. 2008, 14:301-308.
19. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
20. Hur J., Yoon C.H., Lee C.S., Kim T.Y., Oh I.Y., Park K.W., Kim J.H., Lee H.S., Kang H.J., Chae I.H., Oh B.H., Park Y.B., Kim H.S. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 2007, 25:1769-1778.
21. Jiang Z.Y., He Z.H., King B.L., Kuroki T., Opland D.M., Suzuma K., Suzuma I., Ueki K., Kulkarni R.N., Kahn C.R., King G.L. Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis. J. Biol. Chem. 2003, 278:31964-31971.
22. Kang L.N., Chen Q., Wang L., Gao L., Meng K., Chen J.H., Ferro A., Xu B. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin. Exp. Pharmacol. Physiol. 2009, 36:e47-e56.
23. Krankel N., Adams V., Linke A., Gielen S., Erbs S., Lenk K. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2005, 25:698-703.
24. Kuboki K., Jiang Z.Y., Takahara N., Ha S.W., Igarashi M., Yamauchi T., Feener E.P., Herbert T.P., Rhodes C.J., King G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo. Circulation 2000, 101:676-681.
25. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 2000, 342:626-633.
26. Muniyappa R., Montagnani M., Koh K.K., Quon M.J. Cardiovascular actions of insulin. Endocr. Rev. 2007, 28:463-491.
27. Silvestre J.S., Le'vy B.I. Molecular basis of angiopathy in diabetes mellitus. Circ. Res. 2006, 98:4-6.
28. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., Barateau V., Lecomte-Racle t L. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol. 2004, 164:457-466.
29. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J.D. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007, 56:666-674.
30. Waltenberger J. Impaired collateral vessels development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 2001, 49:554-560.
31. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324:1-8.
32. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M., Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005, 353:999-1007.
33. Xu B., Chibber R., Ruggiero D., Kohner E., Ritter J., Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003, 17:1289-1291.
34. You D., Waeckel L., Ebrahimian T.G., Blanc-Brude O., Foubert P., Barateau V., Duriez M., LeRicousse-Roussanne S., Vilar J., Dejana E. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 2006, 114:328-338.
35. Zimny S., Dessel F., Ehren M., Pfohl M., Schatz H. Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diab. Care 2001, 24:1810-1814.